The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction
Open accessAbstract
BACKGROUND: Erectile dysfunction is a common medical problem affecting many men. Although several intracavernosal therapies are available, their efficacy and safety have not been studied systematically. METHODS: We investigated the efficacy and safety of alprostadil formulated for intracavernosal treatment in three separate multi-institutional, prospective studies in men with erectile dysfunction of vasculogenic, neurogenic, psychogenic, and mixed causes. Clinical and laboratory evaluations of erection and the feasibility of satisfactoriness of sexual activity as assessed both by the men and by their partners were the primary measures of efficacy. RESULTS: In a dose-response study of 296 men, all doses of alprostadil were superior to placebo and there was a significant dose-response relation (P < / = 0.001), resulting in higher response rates with increasing doses of alprostadil (from 2.5 to 20 microg). In a dose-finding study of 201 men, the minimal effective dose was < / = 2 microg in 23, 20, 38 and 23 percent of men with erectile dysfunction of neurogenic, vasculogenic, psychogenic, or mixed causes, respectively. In a six-month self-injection study in 683 men, the participants reported being able to have sexual activity after 94 percent of the injections. The men and their partners rated the sexual activity as satisfactory after 87 and 86 percent of the injections, respectively. Penile pain, usually mild, occurred in 50 percent of the men at some time but after only 11 percent of the injections. Prolonged erections occurred in 5 percent of the men, priapism in 1 percent, penile fibrotic complications in 2 percent, and hematoma or ecchymosis in 8 percent. CONCLUSIONS: In men with erectile dysfunction, intracavernosal injection of alprostadil is an effective therapy with tolerable side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260203 · Cited by 1,006
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence
(1993) · JAMA · doi:10.1001/jama.270.1.83 · Cited by 843
Krane, R. J., Goldstein, I., & de Tejada, I. S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912143212406 · Cited by 544
(1991) · doi:10.1172/jci115266 · Cited by 429
The Incidence of Peyronie’s Disease in Rochester, Minnesota, 1950 through 1984
Lindsay, M. B., Schain, D. M., Grambsch, P., Benson, R. C., Beard, C. M., & Kurland, L. T. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37988-0 · Cited by 265
Intracavernous Injection of Prostaglandin E1 in Impotent Men
Stackl, W., Hasun, R., & Marberger, M. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)41488-1 · Cited by 170
Statistical Methodology in the Pharmaceutical Sciences
Berry, D. A. (2014) · CRC Press eBooks · doi:10.1201/b16950 · Cited by 138
Intracavernous prostaglandin E1 in erectile dysfunction
Linet, O. I., & Neff, L. L. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00184593 · Cited by 96
Self-citationColour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men
Amin, Z., Patel, U., Friedman, E. P., Vale, J., Kirby, R. S., & Lees, W. R. (1993) · British Journal of Radiology · doi:10.1259/0007-1285-66-785-398 · Cited by 32
Cited by
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
Erectile dysfunction: AUA guideline
Burnett, A. L., Nehra, A., Breau, R. H., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J., Khera, M., McVary, K. T., Miner, M. M., et al. (2018) · Journal of Urology · doi:10.1016/j.juro.2018.05.004 · Cited by 949
Yafi, F. A., Jenkins, L., Albersen, M., Corona, G., Isidori, A. M., Goldfarb, S., Maggi, M., Nelson, C. J., Parish, S., Salonia, A., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.3 · Cited by 853
Oral Sildenafil in the Treatment of Erectile Dysfunction
(1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390121 · Cited by 622
Metadata
- Authors
- Linet, O. I., & Ogrinc, F. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-04-04
- Volume
- 334
- Issue
- 14
- Pages
- 873-877
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2314125128
- Cited by
- 497
- References
- 11
- FWCI
- 28.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction. https://app.cochat.ai/papers/10.1056/nejm199604043341401
- The paper
- Linet, O. I., & Ogrinc, F. G. (1996). Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction. New England Journal of Medicine. https://doi.org/10.1056/nejm199604043341401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.